Participating in Cancer Research Help Save a 3-Year-Old Girl From Neuroblastoma Cancer

Online, July 8, 2012 (Newswire.com) - Learning your child has been diagnosed with cancer are words a parent never wants to hear. This is news that will change your life as well as your child's life for years to come. Cancer does not discriminate and regardless of your age, you are not invincible and families tend to overlook the facts by thinking this could never happen to them. But cancer does not have to run in your family for your child to be diagnosed with the condition. Luckily, medical professionals across the globe have dedicated, caring individuals to help treat these brave children and show them hope for the future. These are children that often grow up to fulfill big dreams and live a full life. There are treatment centers like Comprehensive Cancer Centers of Nevada (CCCN) that are helping children to dream big, keep fighting and reach their goals.

Through the helping hands of CCCN, 3-year-old Ava Ewing was given a fighting chance when she was diagnosed with a rare form of childhood cancer called Neuroblastoma. This uncommon form of cancer started in her stomach and was not discovered until it had already reached stage 4. Back in the 1990's, the survival rate for children diagnosed with Neuroblastoma was only 40 percent. But through innovative cancer research and clinical trials that have taken place over the past 20 years, the survival rate of this rare form of childhood cancer has climbed to 60 percent. What this means for families who are faced with a child that has cancer is that there is hope and cancer research and clinical trials provide that hope. Ava is actively participating in 1 of more than 128 trials that are currently being conducted for children with cancer.

To learn more about pediatric oncologists providing hope to children and families faced with childhood cancer, visit http://www.cccnevada.com or call (702) 952- 3400. Let one of CCCN's 13 facilities place your child into the trusted hands of award-winning pediatric oncologists who are actively seeking answers through successful cancer research trials.